Exploring the knowledge, perception, and practice of community pharmacists in Saudi Arabia toward pharmacovigilance and adverse drug reaction reporting. A nationwide survey

Amani Khardali

DOI: https://doi.org/10.1038/s41598-024-55664-8

IF: 4.6

2024-02-28

Scientific Reports

Abstract:One of the significant worldwide health problems associated with pharmacovigilance is the under-reporting of adverse drug reactions (ADRs). Reporting suspected ADRs is essential to ensure patient safety, medicine safety, and healthcare quality. The new policy in Saudi Arabia emphasizes pharmacists taking a new clinical role, which may facilitate and improve the documentation of ADRs. Therefore, this study aimed to assess the knowledge and perception of community pharmacists towards the ADRs and their reporting practice in Saudi Arabia. A cross-sectional study using a structured self-administered questionnaire was administered to community pharmacists working in Saudi Arabia. Data were analyzed using descriptive and inferential statistics to identify the association between perceptions and ADR reporting practices. A P value < of 0.05 was considered statistically significant. A response rate of 43% (n = 163) was achieved, of whom 55.2% demonstrated knowledge of PV. Only 16% of community pharmacists were aware of the responsible center for monitoring and collecting ADRs in Saudi Arabia. The key facilitator was offering incentives to pharmacists, and the lack of time was found to be a key barrier among reporter community pharmacists. Positive attitudes toward pharmacovigilance and ADR reporting were expressed by community pharmacists. The findings of this study emphasize the further need for education and training programs and simplifying the ADR reporting process used in Saudi Arabia to enhance the reporting practice.

multidisciplinary sciences

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the knowledge, attitude and practice of community pharmacists in Saudi Arabia regarding adverse drug reactions (ADRs) reporting. Specifically, the study aims to evaluate the knowledge level and perceptions of community pharmacists regarding adverse drug reactions and their reporting practices, and to explore the barriers and facilitators that may influence their reporting behavior.

### Research Background
Adverse drug reactions (ADRs) have a significant impact on the healthcare system, including increasing morbidity, mortality and economic burden. Pharmacovigilance (PV) refers to the science and activities of detecting, evaluating, understanding and preventing drug - related adverse events or problems. However, the under - reporting of adverse drug reactions is a common problem worldwide. In 2009, Saudi Arabia established the National Pharmacovigilance Center (NPC), which is affiliated with the Saudi Food and Drug Administration (SFDA), to strengthen drug safety monitoring. Nevertheless, the participation of community pharmacists in adverse drug reactions reporting remains low.

### Research Objectives
1. **Evaluate Knowledge**: Understand the knowledge level of community pharmacists regarding pharmacovigilance and adverse drug reactions reporting systems.
2. **Evaluate Attitude**: Explore the attitude of community pharmacists towards adverse drug reactions reporting.
3. **Evaluate Practice**: Analyze the adverse drug reactions reporting practice of community pharmacists in actual work.
4. **Identify Barriers and Facilitators**: Explore the barriers and facilitators that affect community pharmacists' reporting of adverse drug reactions.

### Main Findings
- **Knowledge Level**: Most respondents were able to correctly define pharmacovigilance, but knew very little about the institutions responsible for collecting and analyzing adverse drug reactions reports.
- **Attitude**: Most respondents believed that reporting adverse drug reactions was important for patient care and regarded it as a professional obligation.
- **Practice**: Many respondents observed and reported adverse drug reactions in practice, but there were differences in reporting frequency and methods.
- **Barriers**: Lack of time and concerns about legal consequences were the main barriers.
- **Facilitators**: Offering incentives and simplifying the reporting process were the main facilitators.

### Conclusion
Although community pharmacists have a positive attitude towards the importance of adverse drug reactions reporting, there are still knowledge gaps in some aspects. In order to increase the adverse drug reactions reporting rate, further education and training programs need to be carried out, appropriate feedback should be provided, and digital technology should be utilized to simplify the reporting process. These measures will help enhance the reporting enthusiasm of community pharmacists, thereby improving drug safety and medical quality.